A meta-analysis of probiotic and synbiotic use in elective surgery: does nutrition modulation of the gut microbiome improve clinical outcome?

JPEN J Parenter Enteral Nutr. 2013 Mar;37(2):243-53. doi: 10.1177/0148607112452306. Epub 2012 Jul 2.

Abstract

Background: Perioperative nutrition modulation of gut microbiota is increasingly used as a strategy for reducing the infective complications of elective surgery. This meta-analysis assessed the effect of probiotic and synbiotic preparations on the incidence of postoperative sepsis.

Methods: Randomized controlled trials that compared preoperative dosing of probiotics and synbiotics in patients undergoing elective general surgical procedures were included. The primary outcome measure was the postoperative sepsis rate. Pooled outcome measures were determined using random effects models.

Results: Thirteen randomized controlled trials totaling 962 patients were included in this analysis (304 received synbiotics and 182 received probiotics). The incidence of postoperative sepsis was reduced in the probiotic group vs the control (pooled odds ratio [OR] = 0.42; 95% confidence interval [CI], 0.23-0.75; P = .003) and in the synbiotic group vs the control (pooled OR = 0.25; 95% CI, 0.1-0.6; P = .002). However, subgroup analysis failed to identify a significant reduction in the incidence of pneumonia, urinary tract infections, or wound infections in the postoperative phase for either treatment group. Synbiotics reduced the length of postoperative antibiotic use (weighted mean differences = -1.71; 95% CI, -3.2 to -0.21; P = .03).

Conclusion: Probiotic and synbiotic nutrition strategies reduce the incidence of postoperative sepsis in the elective general surgery setting. These effects appear more pronounced with the use of synbiotics. High-powered, mechanistic studies are now required for the optimization of pro- and prebiotic regimens to further improve their efficacy.

Publication types

  • Meta-Analysis

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cross Infection / epidemiology
  • Cross Infection / prevention & control
  • Elective Surgical Procedures / adverse effects*
  • Gastrointestinal Tract / microbiology*
  • Humans
  • Metagenome*
  • Pneumonia / prevention & control
  • Postoperative Complications / prevention & control*
  • Probiotics / therapeutic use*
  • Sepsis / epidemiology
  • Sepsis / prevention & control*
  • Synbiotics*
  • Treatment Outcome
  • Urinary Tract Infections / prevention & control
  • Wound Infection / prevention & control

Substances

  • Anti-Bacterial Agents